[HTML][HTML] PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects

D Miricescu, A Totan, II Stanescu-Spinu… - International journal of …, 2020 - mdpi.com
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …

Epidemiological characteristics of and risk factors for breast cancer in the world

Z Momenimovahed, H Salehiniya - Breast Cancer: Targets and …, 2019 - Taylor & Francis
Aim Breast cancer is the most common cancer among women and one of the most important
causes of death among them. This review aimed to investigate the incidence and mortality …

Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR

DL Monticciolo, MS Newell, L Moy, CS Lee… - Journal of the American …, 2023 - Elsevier
Early detection decreases breast cancer death. The ACR recommends annual screening
beginning at age 40 for women of average risk and earlier and/or more intensive screening …

Cancer statistics for african Americans, 2019

CE DeSantis, KD Miller, A Goding Sauer… - CA: a cancer journal …, 2019 - Wiley Online Library
Abstract In the United States, African American/black individuals bear a disproportionate
share of the cancer burden, having the highest death rate and the lowest survival rate of any …

[HTML][HTML] The role of m6A RNA methylation in cancer

T Sun, R Wu, L Ming - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Abstract N6-methyladenosine (m6A), the most abundant internal modification of RNA in
eukaryotic cells, has gained increasing attention in recent years. The m6A modification …

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence …

FA Vicini, RS Cecchini, JR White, DW Arthur, TB Julian… - The Lancet, 2019 - thelancet.com
Background Whole-breast irradiation after breast-conserving surgery for patients with early-
stage breast cancer decreases ipsilateral breast-tumour recurrence (IBTR), yielding …

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

D Tripathy, SA Im, M Colleoni, F Franke… - The lancet …, 2018 - thelancet.com
Background In MONALEESA-2, ribociclib plus letrozole showed improved progression-free
survival compared with letrozole alone as first-line treatment for postmenopausal patients …

Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening

RA Smith, KS Andrews, D Brooks… - CA: a cancer journal …, 2018 - Wiley Online Library
Abstract Each year, the American Cancer Society publishes a summary of its guidelines for
early cancer detection, data and trends in cancer screening rates from the National Health …

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

V Jain, H Kumar, HV Anod, P Chand, NV Gupta… - Journal of Controlled …, 2020 - Elsevier
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …

[HTML][HTML] The obesity-breast cancer link: a multidisciplinary perspective

EN Devericks, MS Carson, LE McCullough… - Cancer and Metastasis …, 2022 - Springer
Obesity, exceptionally prevalent in the USA, promotes the incidence and progression of
numerous cancer types including breast cancer. Complex, interacting metabolic and …